分子生物学酵素、試薬、キットの市場規模、シェア、動向分析レポート：製品別（キット＆試薬、酵素）、用途別（クローン作成、シーケンス、PCR、エピジェネティクス）、最終用途別、地域別、セグメント予測、2023年～2030年

分子生物学酵素、試薬、キット市場の成長と動向

Grand View Research, Inc.の最新レポートによると、分子生物学酵素、試薬、キットの世界市場規模は2030年までに446億7,000万米ドルに達し、CAGR 9.65%を記録すると予測されている世界の市場の成長は、分子生物学分野における技術の継続的な進歩、感染症や慢性疾患の流行、シークエンシング技術の利用増加、オミックスに基づく研究活動の拡大に起因しています。

COVID-19のパンデミックは、分子生物学酵素、試薬、キットの需要を飛躍的に増大させ、世界の症例の継続的な増加が需要を高水準に維持しました。多くの市場関係者、ヘルスケア組織、学術・研究機関がワクチンの開発に積極的に取り組み、COVID-19の治療のために既存の治療薬を再利用するための研究を増加させました。このような継続的な研究開発活動は、今後数年間、これらの製品の需要を押し上げると予想されます。さらに、SARS-CoV-2ウイルスをより迅速に検出するために、RNA抽出キットのような多くの新製品が主要市場プレーヤーによって発売されました。例えば、2020年6月、Omega Bio-tek, Inc.は、患者サンプルの鼻咽頭ぬぐい液から確実かつ迅速にRNAを分離するための"Mag-Bind Viral RNA Xpress Kit"の発売を発表しました。

合成生物学とマルチオミクス分野への継続的な資金調達と投資は、バイオテクノロジー分野を拡大しています。2022年3月のプレスリリースによると、ブリストル工学生物学センター（BrisEngBio）は、合成生物学の研究と発見を支援する機関です。UKRIの資金提供を受けた研究センターで、これまでに325以上の研究論文を発表し、8つのバイオテクノロジー企業と共同研究を行い、さらに1億1,790万米ドルの研究費を得ています。このように合成生物学とマルチオミクスの分野が急速に進歩することで、教育ツールとしての分子生物学酵素、キット、試薬製品がより広範囲に採用されることになります。そしてこの採用率は、創薬、診断薬開拓、遺伝子治療製造などの革新的手法の開発をさらに促進し、市場を大きく牽引します。

主な市場プレーヤーは、絶え間ない製品の発売と持続的な技術開発を通じて、世界のプレゼンスを拡大しています。買収、提携、共同研究、製造の拡大もまた、市場の収益創出を促進するために主要企業が講じている事業戦略の一部です。例えば、2022年1月、Illumina, Inc.はSomaLogic社との提携を発表し、IlluminaのNGS技術とSomaScanプロテオミクスアッセイを統合した製品を開発しました。この提携は、プロテオミクス市場の急成長するハイスループット分野を強化するものです。

分子生物学酵素、試薬、キット市場のレポートハイライト

• 製品別では、キットと試薬が2022年に最大のシェアを占めました。パンデミックに対応した新しいキットや試薬の発売が、成長を後押ししている主な理由の1つです。さらに、分子生物学キットや試薬が実験室で繰り返し使用されることも成長に寄与しています。
• 用途別では、シングルセルシーケンシングのイントロダクションとNGSの有力な存在により、シーケンシングが2022年に最大のシェアを占めました。ゲノム解析、腫瘍診断、バイオマーカー探索へのNGSの利用が同分野の成長を促進
• 最終用途別では、製薬・バイオテクノロジー分野が2022年に最大のシェアを占めました。医薬品開発パイプラインの存在、臨床試験、継続的な研究開発活動は、分子生物学酵素、キット、試薬の膨大な使用を必要とするため、同分野の成長につながります。
• 北米は2022年に最大の売上シェアを占めました。これは、米国に多数の主要製薬企業やバイオテクノロジー企業が存在することに起因しています。さらに、この地域における疾病の流行と分子診断の利用の増加が収益創出に寄与しています。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの定義
• 情報調達
  • 市場の形成とデータの視覚化
  • データの検証と公開
• 調査の仮定
• 調査手法
  • 購入したデータベース
  • Gvr内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の形成と検証
• モデル詳細
  • 商品フロー分析
• 二次情報のリスト
• 世界市場：CAGRの計算
• 目的

第2章 エグゼクティブサマリー

• 市場スナップショット
• セグメントスナップショット1
• セグメントスナップショット2
• 競合情勢のスナップショット

第3章 分子生物学酵素、試薬、キットの市場変数と動向

• 市場系統の見通し
  • 親市場の見通し
• 市場力学
  • 市場促進要因影響分析
  • 市場抑制要因影響分析
  • 市場機会の影響分析
  • 市場脅威影響分析
• COVID-19のパンデミックの影響
• 業界分析ツール
  • ポーターの分析
  • SWOT分析：要因別（政治・法律、経済・技術）

第4章 分子生物学酵素、試薬、キット市場：製品推定・動向分析

• 製品変動分析と市場シェア、2022年と2030年
• 製品別
• キットと試薬
  • 世界のキットおよび試薬市場推計・予測、2018～2030年（100万米ドル）
• 酵素
  • 世界の酵素市場推計・予測、2018年から2030年（100万米ドル）

第5章 分子生物学酵素、試薬、キット市場：用途の推定・動向分析

• 用途の変動分析と市場シェア、2022年と2030年
• 用途別
• クローン作成
  • 世界のクローン市場推計・予測、2018～2030年（100万米ドル）
• シーケンス
  • 世界のシーケンス市場推計・予測、2018～2030年（100万米ドル）
• ＰＣＲ
  • 世界のPCR市場推計・予測、2018～2030年（100万米ドル）
• エピジェネティクス
  • 世界のエピジェネティクス市場推計・予測、2018年から2030年（100万米ドル）
• 制限消化
  • 世界の制限消化市場推計・予測、2018年から2030年（100万米ドル）
• その他
  • 世界のその他市場推計・予測、2018-2030（100万米ドル）

第6章 分子生物学酵素、試薬、キット市場：最終用途の推定・動向分析

• 最終用途の変動分析と市場シェア、2022年と2030年
• 最終用途別
• 製薬およびバイオテクノロジー
  • 世界の製薬およびバイオテクノロジー市場推計・予測、2018～2030年（100万米ドル）
• 学術と調査
  • 世界の学術および調査市場推計・予測、2018年から2030年（100万米ドル）
• 病院と診断
  • 世界の病院および診断市場推計・予測、2018～2030年（100万米ドル）
• その他
  • 世界のその他市場推計・予測、2018-2030（100万米ドル）

第7章 分子生物学酵素、試薬、キット市場：地域推定・動向分析

• 分子生物学酵素、試薬、キット市場：地域別の展望
• 北米
  • 北米の分子生物学酵素、試薬、キット市場推計・予測、2018年から2030年（100万米ドル）
  • 米国
  • カナダ
• 欧州
  • 欧州の分子生物学酵素、試薬、キット市場推計・予測、2018年から2030年（100万米ドル）
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • アジア太平洋地域の分子生物学酵素、試薬、キット市場推計・予測、2018年から2030年（100万米ドル）
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカの分子生物学酵素、試薬、キット市場推計・予測、2018年から2030年（100万米ドル）
  • ブラジル
  • メキシコ
  • アルゼンチン
• MEA
  • MEAの分子生物学酵素、試薬、キット市場推計・予測、2018～2030年（100万米ドル）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 分子生物学酵素、試薬、キット市場：競合情勢

• 市場参入企業
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen
  • Promega Corporation
  • New England Biolabs
  • Merck Kgaa
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Takara Bio, Inc.
  • Lgc Limited
• 参加者の概要
• 財務実績
• 製品のベンチマーク
• 企業の市場シェア分析、2022年
• 戦略マッピング
  • 事業拡大
  • 取得
  • 製品/サービスの開始
  • その他

第9章 アナリストの視点

List of Tables

• Table 1 List of secondary sources
• Table 2 List of Abbreviations
• Table 3 Global Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 4 Global Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 5 Global Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 6 North America Molecular Biology Enzymes, Kits, & Reagents Market, by Country, 2018 - 2030 (USD Million)
• Table 7 North America Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 8 North America Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 9 North America Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 10 Europe Molecular Biology Enzymes, Kits, & Reagents Market, by Country, 2018 - 2030 (USD Million)
• Table 11 Europe Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 12 Europe Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 13 Europe Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 14 Asia Pacific Molecular Biology Enzymes, Kits, & Reagents Market, by Country, 2018 - 2030 (USD Million)
• Table 15 Asia Pacific Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 16 Asia Pacific Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 17 Asia Pacific Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 18 Latin America Molecular Biology Enzymes, Kits, & Reagents Market, by Country, 2018 - 2030 (USD Million)
• Table 19 Latin America Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 20 Latin America Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 21 Latin America Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 22 Middle East & Africa Molecular Biology Enzymes, Kits, & Reagents Market, by Country, 2018 - 2030 (USD Million)
• Table 23 Middle East & Africa Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 24 Middle East & Africa Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 25 Middle East & Africa Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 26 U.S. Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 27 U.S. Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 28 U.S. Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 29 Canada Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 30 Canada Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 31 Canada Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 32 Germany Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 33 Germany Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 34 Germany Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 35 U.K. Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 36 U.K. Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 37 U.K. Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 38 France Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 39 France Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 40 France Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 41 Italy Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 42 Italy Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 43 Italy Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 44 Spain Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 45 Spain Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 46 Spain Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 47 Denmark Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 48 Denmark Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 49 Denmark Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 50 Sweden Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 51 Sweden Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 52 Sweden Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 53 Norway Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 54 Norway Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 55 Norway Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 56 China Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 57 China Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 58 China Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 59 Japan Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 60 Japan Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 61 Japan Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 62 India Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 63 India Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 64 India Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 65 Australia Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 66 Australia Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 67 Australia Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 68 Thailand Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 69 Thailand Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 70 Thailand Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 71 South Korea Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 72 South Korea Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 73 South Korea Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 74 Brazil Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 75 Brazil Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 76 Brazil Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 77 Mexico Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 78 Mexico Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 79 Mexico Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 80 Argentina Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 81 Argentina Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 82 Argentina Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 83 South Africa Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 84 South Africa Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 85 South Africa Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 89 UAE Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 90 UAE Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 91 UAE Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 92 Kuwait Molecular Biology Enzymes, Kits, & Reagents Market, by Product, 2018 - 2030 (USD Million)
• Table 93 Kuwait Molecular Biology Enzymes, Kits, & Reagents Market, by Application, 2018 - 2030 (USD Million)
• Table 94 Kuwait Molecular Biology Enzymes, Kits, & Reagents Market, by End-use, 2018 - 2030 (USD Million)
• Table 95 Company Overview
• Table 96 Financial Performance
• Table 97 Product Benchmarking
• Table 98 Strategic Initiatives

List of Figures

• Fig. 1 Molecular Biology Enzymes, Reagents And Kits market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation

Fig. 9 Market Outlook (2022)

• Fig. 10 Segment Outlook
• Fig. 11 Strategy framework
• Fig. 12 Market driver relevance analysis (current & future impact)
• Fig. 13 Market restraint relevance analysis (current & future impact)
• Fig. 14 Porter's five forces analysis
• Fig. 15 Swot analysis, by factor (political & legal, economic and technological)
• Fig. 16 Molecular biology enzymes, kits, and reagents market: Product outlook and key takeaways
• Fig. 17 Molecular biology enzymes, reagents, and kits market: Product movement analysis
• Fig. 18 Global molecular biology kits & reagents market, 2018 - 2030 (USD million)
• Fig. 19 Global molecular biology enzymes market, 2018 - 2030 (USD million)
• Fig. 20 Molecular biology enzymes, kits, and reagents market: Application outlook and key takeaways
• Fig. 21 Molecular biology enzymes, reagents, and kits market: Application movement analysis
• Fig. 22 Global molecular biology enzymes, reagents, and kits market for cloning, 2018 - 2030 (USD Million)
• Fig. 23 Global molecular biology enzymes, reagents, and kits market for sequencing, 2018 - 2030 (USD Million)
• Fig. 24 Global molecular biology enzymes, reagents, and kits market for PCR, 2018 - 2030 (USD Million)
• Fig. 25 Global molecular biology enzymes, reagents, and kits market for sequencing, 2018 - 2030 (USD Million)
• Fig. 26 Global molecular biology enzymes, reagents, and kits market for restriction digestion, 2018 - 2030 (USD Million)
• Fig. 27 Global molecular biology enzymes, reagents, and kits market for other applications, 2018 - 2030 (USD Million)
• Fig. 28 Molecular biology enzymes, reagents, and kits market: End-use outlook and key takeaways
• Fig. 29 Molecular biology enzymes, reagents, and kits market: End-use movement analysis
• Fig. 30 Global molecular biology enzymes, reagents, and kits market for pharma & biotech, 2018 - 2030 (USD Million)
• Fig. 31 Global molecular biology enzymes, reagents, and kits market for academic & research, 2018 - 2030 (USD Million)
• Fig. 32 Global molecular biology enzymes, reagents, and kits market for hospital & diagnostics, 2018 - 2030 (USD Million)
• Fig. 33 Global molecular biology enzymes, reagents, and kits market for others, 2018 - 2030 (USD Million)
• Fig. 34 Molecular biology enzymes, reagents, and kits market: Regional outlook and key takeaways
• Fig. 35 Molecular biology enzymes, reagents, and kits market: Regional movement analysis, 2021 and 2030
• Fig. 36 North America molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 U.S. molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Canada molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Europe molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Germany molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 U.K. molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 France molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Italy molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Spain molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Denmark molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Sweden molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Norway molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Asia Pacific molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 49 Japan molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 China molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 India molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Australia molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Thailand molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 South Korea molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Latin America molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Brazil molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 Mexico molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Argentina molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 MEA molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 South Africa molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Saudi Arabia molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 UAE molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Kuwait molecular biology enzymes, reagents, and kits market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 List of secondary sources

Molecular Biology Enzymes, Reagents, and Kits Market Growth & Trends

The global molecular biology enzymes, reagents, and kits market size is expected to reach USD 44.67 billion by 2030, registering a CAGR of 9.65%, according to a new report by Grand View Research, Inc The growth of the market globally can be attributed to continuous advancement in technologies in the molecular biology field, the prevalence of infectious and chronic diseases, increased usage of sequencing technologies and growing omics-based research activities.

The COVID-19 pandemic exponentially increased the demand for molecular biology enzymes, reagents, and kits, and the continuous rise in cases worldwide kept the demand on the higher side. Many market players, healthcare organizations, and academic and research institutes were actively engaged in the development of vaccines and they increased the research for repurposing the existing therapeutics for the treatment of COVID-19 infection. This continuous R&D activity is expected to boost the demand for these products in the coming years. Moreover, in an effort to detect the SARS-CoV-2 virus faster, many new products were launched by the key market players, such as RNA extraction kits. For example, in June 2020, Omega Bio-tek, Inc. announced the launch of its "Mag-Bind Viral RNA Xpress Kit" for RNA isolation in a reliable and rapid manner from the nasopharyngeal swab of patient samples.

Continuous funding and investments in the field of synthetic biology and multi-omics are expanding the field of biotechnology. As per a press release in March 2022, The Bristol Centre for Engineering Biology, BrisEngBio, is an institute that supports research and discovery in synthetic biology. It is a UKRI-funded research center that has published over 325 research papers, collaborated with 8 biotech companies, and received an additional USD 117.90 million for research. This rapidly advancing field of synthetic biology and multi-omics will result in more extensive adoption of molecular biology, enzymes, kits, and reagent products, which serve as educational tools. And this adoption rate further enhances the development of innovative methods such as drug discovery, diagnostics development, and gene therapies manufacturing, hence driving the market significantly.

The key market players are expanding their global presence through never-ceasing product launches and sustained technological developments. Acquisitions, partnerships, collaborations, and manufacturing expansions are also some of the business strategies taken up by the key players to drive revenue generation in the market. For example, in January 2022, Illumina, Inc. announced a partnership with SomaLogic to develop a product by integrating Illumina's NGS technology with SomaScan Proteomics Assay. This partnership bolsters the rapidly growing high-throughput segment of the proteomics market.

Molecular Biology Enzymes, Reagents, and Kits Market Report Highlights

• By product, the kits and reagents held the largest share in 2022. The launch of new kits and reagents in response to the pandemic is one of the key reasons fueling the growth. Moreover, the repeated use of molecular biology kits and reagents in laboratory setups contributes to the growth
• By application, sequencing accounted for the largest share in 2022 due to the introduction of single-cell sequencing and the leading presence of NGS. Use of NGS for analysis of genomics, tumor diagnostics, and biomarker discovery fuels the segment growth
• By end-use, the pharma and biotech segment held the largest share in 2022. The presence of drug development pipelines, clinical trials, and continuous R&D activities require huge usage of molecular biology enzymes, kits, and reagents, thus leading to the segment growth
• North America held the largest revenue share in 2022. This is attributed to the presence of numerous key pharmaceutical and biotechnology companies in the U.S. Furthermore, the prevalence of diseases in this region and increased use of molecular diagnostics contribute to revenue generation

Table of Contents

Chapter 1. Methodology And Scope

• 1.1. Market Segmentation And Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Product Segment
    • 1.1.1.2. Application Segment
    • 1.1.1.3. End-Use Segment
• 1.2. Information Procurement
  • 1.2.1. Market Formulation & Data Visualization
  • 1.2.2. Data Validation & Publishing
• 1.3. Research Assumptions
• 1.4. Research Methodology
  • 1.4.1. Purchased Database
  • 1.4.2. Gvrs Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details Of Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
    • 1.7.1.1. Approach 1: Commodity Flow Approach
• 1.8. List Of Secondary Sources
• 1.9. Global Market: Cagr Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot 1
• 2.3. Segment Snapshot 2
• 2.4. Competitive Landscape Snapshot

Chapter 3. Molecular Biology Enzymes, Reagents And Kits Market Variables And Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Impact Analysis
    • 3.2.1.1. Technological Advancements In The Molecular Biology Arena
    • 3.2.1.2. Rising Incidence Of Infectious Diseases And Genetic Disorders
    • 3.2.1.3. Expanding Applications Of Sequencing Technology In Molecular Biology
    • 3.2.1.4. Increase In Omics - Based R&D Programs
  • 3.2.2. Market Restraint Impact Analysis
    • 3.2.2.1. Challenges In Maintaining Privacy Of Genetic Information
    • 3.2.2.2. Reimbursement Challenges For Molecular Diagnostics
  • 3.2.3. Market Opportunities Impact Analysis
    • 3.2.3.1. Funding And Investments In The Field Of Synthetic Biology And Epigenomics
    • 3.2.3.2. Emergence Of Single - Cell Sequencing
  • 3.2.4. Market Threat Impact Analysis
    • 3.2.4.1. Challenges Pertaining To Molecular Profiling
    • 3.2.4.2. Routine Challenges In Molecular Biology
• 3.3. Impact Of Covid-19 Pandemic
• 3.4. Industry Analysis Tools
  • 3.4.1. Porter's Analysis
  • 3.4.2. Swot Analysis; By Factor (Political & Legal, Economic And Technological)

Chapter 4. Molecular Biology Enzymes, Reagents And Kits Market: Product Estimates & Trend Analysis

• 4.1. Product Movement Analysis & Market Share, 2022 & 2030
• 4.2. Molecular Biology Enzymes, Reagents And Kits Market Estimates & Forecast, By Product (USD Million)
• 4.3. Kits & Reagents
  • 4.3.1. Global Kits & Reagents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.4. Enzymes
  • 4.4.1. Global Enzymes Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Molecular Biology Enzymes, Reagents And Kits Market: Application Estimates & Trend Analysis

• 5.1. Application Movement Analysis & Market Share, 2022 & 2030
• 5.2. Molecular Biology Enzymes, Reagents And Kits Market Estimates & Forecast, By Application (USD Million)
• 5.3. Cloning
  • 5.3.1. Global Cloning Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.4. Sequencing
  • 5.4.1. Global Sequencing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.5. Pcr
  • 5.5.1. Global Pcr Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.6. Epigenetics
  • 5.6.1. Global Epigenetics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.7. Restriction Digestion
  • 5.7.1. Global Restriction Digestion Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Molecular Biology Enzymes, Reagents And Kits Market: End-Use Estimates & Trend Analysis

• 6.1. End-Use Movement Analysis & Market Share, 2022 & 2030
• 6.2. Molecular Biology Enzymes, Reagents And Kits Market Estimates & Forecast, By End-Use (USD Million)
• 6.3. Pharma & Biotech
  • 6.3.1. Global Pharma & Biotech Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.4. Academic & Research
  • 6.4.1. Global Academic & Research Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.5. Hospital & Diagnostics
  • 6.5.1. Global Hospital & Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Molecular Biology Enzymes, Reagents And Kits Market: Regional Estimates And Trend Analysis

• 7.1. Molecular Biology Enzymes, Reagents And Kits Market: Regional Outlook
• 7.2. North America
  • 7.2.1. North America Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Target Disease Prevalence
    • 7.2.2.3. Competitive Scenario
    • 7.2.2.4. Regulatory Framework
    • 7.2.2.5. Reimbursement Scenario
    • 7.2.2.6. U.S. Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Target Disease Prevalence
    • 7.2.3.3. Competitive Scenario
    • 7.2.3.4. Regulatory Framework
    • 7.2.3.5. Reimbursement Scenario
    • 7.2.3.6. Canada Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. Germany
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Target Disease Prevalence
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. Regulatory Framework
    • 7.3.2.5. Reimbursement Scenario
    • 7.3.2.6. Germany Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Uk
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Target Disease Prevalence
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Regulatory Framework
    • 7.3.3.5. Reimbursement Scenario
    • 7.3.3.6. Uk Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Target Disease Prevalence
    • 7.3.4.3. Competitive Scenario
    • 7.3.4.4. Regulatory Framework
    • 7.3.4.5. Reimbursement Scenario
    • 7.3.4.6. France Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Target Disease Prevalence
    • 7.3.5.3. Competitive Scenario
    • 7.3.5.4. Regulatory Framework
    • 7.3.5.5. Reimbursement Scenario
    • 7.3.5.6. Italy Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Target Disease Prevalence
    • 7.3.6.3. Competitive Scenario
    • 7.3.6.4. Regulatory Framework
    • 7.3.6.5. Reimbursement Scenario
    • 7.3.6.6. Spain Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Target Disease Prevalence
    • 7.3.7.3. Competitive Scenario
    • 7.3.7.4. Regulatory Framework
    • 7.3.7.5. Reimbursement Scenario
    • 7.3.7.6. Denmark Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Target Disease Prevalence
    • 7.3.8.3. Competitive Scenario
    • 7.3.8.4. Regulatory Framework
    • 7.3.8.5. Reimbursement Scenario
    • 7.3.8.6. Sweden Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Target Disease Prevalence
    • 7.3.9.3. Competitive Scenario
    • 7.3.9.4. Regulatory Framework
    • 7.3.9.5. Reimbursement Scenario
    • 7.3.9.6. Norway Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Target Disease Prevalence
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Regulatory Framework
    • 7.4.2.5. Reimbursement Scenario
    • 7.4.2.6. Japan Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Regulatory Framework
    • 7.4.3.5. Reimbursement Scenario
    • 7.4.3.6. China Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. Regulatory Framework
    • 7.4.4.5. Reimbursement Scenario
    • 7.4.4.6. India Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. South Korea
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Target Disease Prevalence
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Regulatory Framework
    • 7.4.5.5. Reimbursement Scenario
    • 7.4.5.6. South Korea Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Australia
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Target Disease Prevalence
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
    • 7.4.6.5. Reimbursement Scenario
    • 7.4.6.6. Australia Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Thailand
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Target Disease Prevalence
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Regulatory Framework
    • 7.4.7.5. Reimbursement Scenario
    • 7.4.7.6. Thailand Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Target Disease Prevalence
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Regulatory Framework
    • 7.5.2.5. Reimbursement Scenario
    • 7.5.2.6. Brazil Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Regulatory Framework
    • 7.5.3.5. Reimbursement Scenario
    • 7.5.3.6. Mexico Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Argentina
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Target Disease Prevalence
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Regulatory Framework
    • 7.5.4.5. Reimbursement Scenario
    • 7.5.4.6. Argentina Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Target Disease Prevalence
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Regulatory Framework
    • 7.6.2.5. Reimbursement Scenario
    • 7.6.2.6. South Africa Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Regulatory Framework
    • 7.6.3.5. Reimbursement Scenario
    • 7.6.3.6. Saudi Arabia Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Target Disease Prevalence
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Regulatory Framework
    • 7.6.4.5. Reimbursement Scenario
    • 7.6.4.6. UAE Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Target Disease Prevalence
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Regulatory Framework
    • 7.6.5.5. Reimbursement Scenario
    • 7.6.5.6. Kuwait Molecular Biology Enzymes, Reagents And Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Molecular Biology Enzymes, Reagents And Kits Market: Competitive Landscape

• 8.1. Participant Categorization
  • 8.1.1. Thermo Fisher Scientific, Inc.
    • 8.1.1.1. Overview
    • 8.1.1.2. Product Benchmarking
    • 8.1.1.3. Strategic Initiatives
  • 8.1.2. Illumina, Inc.
    • 8.1.2.1. Overview
    • 8.1.2.2. Product Benchmarking
    • 8.1.2.3. Strategic Initiatives
  • 8.1.3. Agilent Technologies, Inc.
    • 8.1.3.1. Overview
    • 8.1.3.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
    • 8.1.3.3. Product Benchmarking
    • 8.1.3.4. Strategic Initiatives
  • 8.1.4. Qiagen
    • 8.1.4.1. Overview
    • 8.1.4.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
    • 8.1.4.3. Product Benchmarking
    • 8.1.4.4. Strategic Initiatives
  • 8.1.5. Promega Corporation
    • 8.1.5.1. Overview
    • 8.1.5.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
    • 8.1.5.3. Product Benchmarking
    • 8.1.5.4. Strategic Initiatives
  • 8.1.6. New England Biolabs
    • 8.1.6.1. Overview
    • 8.1.6.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
    • 8.1.6.3. Product Benchmarking
    • 8.1.6.4. Strategic Initiatives
  • 8.1.7. Merck Kgaa
    • 8.1.7.1. Overview
    • 8.1.7.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
    • 8.1.7.3. Product Benchmarking
    • 8.1.7.4. Strategic Initiatives
  • 8.1.8. F. Hoffmann-La Roche Ltd.
    • 8.1.8.1. Overview
    • 8.1.8.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
    • 8.1.8.3. Product Benchmarking
    • 8.1.8.4. Strategic Initiatives
  • 8.1.9. Bio-Rad Laboratories, Inc.
    • 8.1.9.1. Overview
    • 8.1.9.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
    • 8.1.9.3. Product Benchmarking
    • 8.1.9.4. Strategic Initiatives
  • 8.1.10. Takara Bio, Inc.
    • 8.1.10.1. Overview
    • 8.1.10.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
    • 8.1.10.3. Product Benchmarking
    • 8.1.10.4. Strategic Initiatives
  • 8.1.11. Lgc Limited
    • 8.1.11.1. Overview
    • 8.1.11.2. Financial Performance (Net Revenue/Sales/Ebitda/Gross Profit)
    • 8.1.11.3. Product Benchmarking
    • 8.1.11.4. Strategic Initiatives
• 8.2. Participant's Overview
• 8.3. Financial Performance
• 8.4. Product Benchmarking
• 8.5. Company Market Share Analysis, 2022
• 8.6. Strategy Mapping
  • 8.6.1. Expansion
  • 8.6.2. Acquisition
  • 8.6.3. Product/Service Launch
  • 8.6.4. Others

Chapter 9. Analyst View